These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29548576)

  • 1. Design, synthesis, and biological evaluation of novel ubiquitin-activating enzyme inhibitors.
    Itoh Y; Suzuki M
    Bioorg Med Chem Lett; 2018 Sep; 28(16):2723-2727. PubMed ID: 29548576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ubiquitin-activating enzyme E1 as a therapeutic target for the treatment of leukemia and multiple myeloma.
    Xu GW; Ali M; Wood TE; Wong D; Maclean N; Wang X; Gronda M; Skrtic M; Li X; Hurren R; Mao X; Venkatesan M; Beheshti Zavareh R; Ketela T; Reed JC; Rose D; Moffat J; Batey RA; Dhe-Paganon S; Schimmer AD
    Blood; 2010 Mar; 115(11):2251-9. PubMed ID: 20075161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide prodrug JS-K inhibits ubiquitin E1 and kills tumor cells retaining wild-type p53.
    Kitagaki J; Yang Y; Saavedra JE; Colburn NH; Keefer LK; Perantoni AO
    Oncogene; 2009 Jan; 28(4):619-24. PubMed ID: 18978812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel NAE/UAE dual inhibitor LP0040 blocks neddylation and ubiquitination leading to growth inhibition and apoptosis of cancer cells.
    Lu P; Guo Y; Zhu L; Xia Y; Zhong Y; Wang Y
    Eur J Med Chem; 2018 Jun; 154():294-304. PubMed ID: 29843100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibiting Hdm2 and ubiquitin-activating enzyme: targeting the ubiquitin conjugating system in cancer.
    Weissman AM; Yang Y; Kitagaki J; Sasiela CA; Beutler JA; O'Keefe BR
    Ernst Schering Found Symp Proc; 2008; (1):171-90. PubMed ID: 19202599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Largazole and its derivatives selectively inhibit ubiquitin activating enzyme (e1).
    Ungermannova D; Parker SJ; Nasveschuk CG; Wang W; Quade B; Zhang G; Kuchta RD; Phillips AJ; Liu X
    PLoS One; 2012; 7(1):e29208. PubMed ID: 22279528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of quinazolinyloxy biaryl urea as a new class of SUMO activating enzyme 1 inhibitors.
    Kumar A; Ito A; Hirohama M; Yoshida M; Zhang KY
    Bioorg Med Chem Lett; 2013 Sep; 23(18):5145-9. PubMed ID: 23920437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of novel spiro-pentacylamides as acetyl-CoA carboxylase inhibitors.
    Wei Q; Mei L; Yang Y; Ma H; Chen H; Zhang H; Zhou J
    Bioorg Med Chem; 2018 Aug; 26(14):3866-3874. PubMed ID: 30049586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the ubiquitin E1 as a novel anti-cancer strategy.
    Xu W; Lukkarila JL; da Silva SR; Paiva SL; Gunning PT; Schimmer AD
    Curr Pharm Des; 2013; 19(18):3201-9. PubMed ID: 23151135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and mechanistic studies of a novel ubiquitin E1 inhibitor.
    Ungermannova D; Parker SJ; Nasveschuk CG; Chapnick DA; Phillips AJ; Kuchta RD; Liu X
    J Biomol Screen; 2012 Apr; 17(4):421-34. PubMed ID: 22274912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based identification of a NEDD8-activating enzyme inhibitor via drug repurposing.
    Wu KJ; Zhong HJ; Li G; Liu C; Wang HD; Ma DL; Leung CH
    Eur J Med Chem; 2018 Jan; 143():1021-1027. PubMed ID: 29232579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a new class of natural product MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities and target validation.
    Qin JJ; Wang W; Voruganti S; Wang H; Zhang WD; Zhang R
    Oncotarget; 2015 Feb; 6(5):2623-40. PubMed ID: 25739118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designed semisynthetic protein inhibitors of Ub/Ubl E1 activating enzymes.
    Lu X; Olsen SK; Capili AD; Cisar JS; Lima CD; Tan DS
    J Am Chem Soc; 2010 Feb; 132(6):1748-9. PubMed ID: 20099854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of Pontin ATPase inhibitors through a molecular docking approach.
    Elkaim J; Lamblin M; Laguerre M; Rosenbaum J; Lestienne P; Eloy L; Cresteil T; Felpin FX; Dessolin J
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2512-6. PubMed ID: 24767849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New comprehensive studies of a gold(III) Dithiocarbamate complex with proven anticancer properties: Aqueous dissolution with cyclodextrins, pharmacokinetics and upstream inhibition of the ubiquitin-proteasome pathway.
    Tomasello MF; Nardon C; Lanza V; Di Natale G; Pettenuzzo N; Salmaso S; Milardi D; Caliceti P; Pappalardo G; Fregona D
    Eur J Med Chem; 2017 Sep; 138():115-127. PubMed ID: 28651154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in vitro anticancer evaluation of some 4,6-diamino-1,3,5-triazine-2-carbohydrazides as Rad6 ubiquitin conjugating enzyme inhibitors.
    Kothayer H; Spencer SM; Tripathi K; Westwell AD; Palle K
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2030-4. PubMed ID: 26965855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics.
    Yang Y; Kitagaki J; Dai RM; Tsai YC; Lorick KL; Ludwig RL; Pierre SA; Jensen JP; Davydov IV; Oberoi P; Li CC; Kenten JH; Beutler JA; Vousden KH; Weissman AM
    Cancer Res; 2007 Oct; 67(19):9472-81. PubMed ID: 17909057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enantio- and diastereoselective total synthesis of (+)-panepophenanthrin, a ubiquitin-activating enzyme inhibitor, and biological properties of its new derivatives.
    Matsuzawa M; Kakeya H; Yamaguchi J; Shoji M; Onose R; Osada H; Hayashi Y
    Chem Asian J; 2006 Dec; 1(6):845-51. PubMed ID: 17441127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based design, synthesis and evaluation of novel anthra[1,2-d]imidazole-6,11-dione derivatives as telomerase inhibitors and potential for cancer polypharmacology.
    Chen CL; Chang DM; Chen TC; Lee CC; Hsieh HH; Huang FC; Huang KF; Guh JH; Lin JJ; Huang HS
    Eur J Med Chem; 2013 Feb; 60():29-41. PubMed ID: 23279865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis, and Biological Evaluation of Lysine Demethylase 5 C Degraders.
    Iida T; Itoh Y; Takahashi Y; Yamashita Y; Kurohara T; Miyake Y; Oba M; Suzuki T
    ChemMedChem; 2021 May; 16(10):1609-1618. PubMed ID: 33470543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.